These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3653228)

  • 1. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Sica DA; Comstock T; Harford A; Eshelman F
    Eur J Clin Pharmacol; 1987; 32(6):587-91. PubMed ID: 3653228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine bioavailability and disposition kinetics in patients undergoing chronic hemodialysis.
    Comstock TJ; Sica DA; Harford A; Eshelman F
    Nephron; 1989; 52(1):15-9. PubMed ID: 2710266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ranitidine in patients undergoing haemofiltration.
    Gladziwa U; Krishna DR; Klotz U; Ittel TH; Schunkert H; Glöckner WM; Mann H
    Eur J Clin Pharmacol; 1988; 35(4):427-30. PubMed ID: 3197752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of absorbed aluminum in patients undergoing continuous ambulatory peritoneal dialysis.
    Wilhelm M; Passlick J; Busch T; Ohnesorge FK
    J Toxicol Clin Toxicol; 1988; 26(3-4):209-21. PubMed ID: 3418776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysis.
    Bailie GR; Waldek S
    J Clin Pharm Ther; 1988 Apr; 13(2):121-4. PubMed ID: 3134365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
    Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
    Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ranitidine in patients with renal failure.
    Garg DC; Baltodano N; Jallad NS; Perez G; Oster JR; Eshelman FN; Weidler DJ
    J Clin Pharmacol; 1986 Apr; 26(4):286-91. PubMed ID: 3700684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
    Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
    Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
    Bliss M; Mayersohn M; Arnold T; Logan J; Michael UF; Jones W
    Antimicrob Agents Chemother; 1986 Apr; 29(4):649-53. PubMed ID: 3707113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
    Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
    Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
    Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis.
    Sica DA; Yonce C; Small R; Cefali E; Harford A; Poynor W
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):59-64. PubMed ID: 2457560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.